Table 1.
Characteristics of participants in the customized career development platform trial at 2020 and 2021
| Characteristic | 2020 | 2021 | ||
|---|---|---|---|---|
| n = 312 | (%) | n = 175 | (%) | |
| Age (median, 25th–75th percentile) | 35 | (30–38) | 35 | (30–37) |
| Gender | ||||
| Male | 127 | (40.8) | 68 | (38.9) |
| Female | 179 | (57.7) | 104 | (59.4) |
| Gender minority/prefer not to answer | 5 | (1.6) | 3 | (1.7) |
| Race | ||||
| White | 197 | (64.0) | 110 | (62.9) |
| Black | 32 | (10.4) | 14 | (8.0) |
| Asian | 48 | (15.6) | 31 | (17.7) |
| Multi-race | 14 | (4.6) | 12 | (6.9) |
| Other/prefer not to answer | 17 | (5.6) | 8 | (4.6) |
| Hispanic/Latinx ethnicity | ||||
| Yes | 27 | (8.8) | 13 | (7.4) |
| No | 268 | (87.0) | 154 | (88.0) |
| Prefer not to answer | 13 | (4.2) | 8 | (4.6) |
| Disadvantaged background | ||||
| Yes | 66 | (21.2) | 35 | (20.0) |
| No | 239 | (76.9) | 136 | (77.7) |
| Prefer not to answer | 6 | (1.9) | 4 | (2.3) |
| Underrepresented in sciences | ||||
| Yes | 99 | (33.2) | 51 | (30.4) |
| No | 199 | (66.8) | 117 | (69.6) |
| Highest degree | ||||
| MD | 107 | (34.3) | 62 | (35.4) |
| PhD | 146 | (46.8) | 84 | (48.0) |
| Other | 59 | (18.9) | 29 | (16.6) |
| Career status | ||||
| Post-doctoral fellow | 136 | (43.6) | 72 | (41.1) |
| Faculty | 176 | (56.4) | 103 | (58.9) |
| Research affected by COVID-19 pandemic a | 266 | (85.3) | 142 | (81.1) |
| Ways research affected by COVID-19 pandemic | ||||
| Prevented me from completing research as planned | 183 | (58.7) | 107 | (61.1) |
| Decreased access to necessary resources | 150 | (48.1) | 88 | (50.3) |
| Competing demands for my time | 168 | (53.9) | 88 | (50.3) |
| Decreased collaboration | 83 | (26.6) | 45 | (25.7) |
| Increased collaboration | 31 | (9.9) | 20 | (11.4) |
| Increased productivity | 29 | (9.3) | 18 | (10.3) |
| Decreased productivity | 177 | (56.7) | 77 | (44.0) |
| Increased funds | 18 | (5.8) | 8 | (4.6) |
| New avenues of research | 53 | (17.0) | 28 | (16.0) |
| Added a COVID-19 research opportunity to my portfolio | 69 | (22.1) | 30 | (17.1) |
| Number of positive ways research affected by the COVID-19 pandemic b (median, 25th–75th percentile) | 0 | (0–1) | 0 | (0–1) |
| Number of negative ways research affected by the COVID-19 pandemic c (median, 25th–75th percentile) | 3 | (1–4) | 3 | (1–4) |
a
Impact of COVID-19 Survey Questions in Supplemental Table 1.
b
Includes increased collaboration, increased productivity, increased funding opportunities, new avenues of research, and added a COVID-19 research opportunity to my research portfolio.
c
Includes prevented me from completing research as planned, decreased access to necessary resources and materials, competing demands for my time, decreased collaboration, and decreased productivity.